Lower-cost "biosimilars" are coming to the U.S. Gillian Woollett, chief scientist with Engel & Novitt LLP, discusses the implications for drug companies, supply-chain managers and patients.
Jim Burleigh, chief executive officer of SmartTurn, talks about the challenges faced by small and medium-sized companies in a time of tight budgets, slow demand and stricter government regulations.
Those specialized sectors, with their need for strict regulatory compliance and product control, have lagged other industries in the use of third-party service providers. But the picture is beginning to change, says Angela Watson, UPS's vice president of enterprise sales for the healthcare sector.
Rod Derifield, chief executive officer of Envirocooler LLC, outlines some of the new ideas and technology that providers are deploying to boost efficiencies in the movement of temperature-controlled pharmaceuticals.
The Georgia Center of Innovation for Logistics is unique in that it is a state-led and state-funded organization, created to foster logistics as a strategic resource for fueling competitiveness and economic development in the state. The Center is hosted by the Georgia Institute of Technology.
The company searches for a lead logistics provider that can meet the needs of the highly regulated medical equipment industry. James Matney, global logistics manager, reports on the results.